Terminology Service for NFDI4Health
All terms in SNOMED
| Label | Id | Description |
|---|---|---|
| Mold (organism) | 84489001 | |
| Product containing precisely buprenorphine 5 microgram/1 hour prolonged-release transdermal patch (clinical drug) | 1231483005 | |
| Eosinophilic degeneration (morphologic abnormality) | 385504003 | |
| Fungal colonization of urinary tract (finding) | 23011000175109 | |
| Light wand (physical object) | 261910005 | |
| High protein diet education (procedure) | 183067004 | |
| Edition (attribute) | 277047001 | |
| Hemoglobin Okaloosa (substance) | 102002 | |
| Measurement of beta 2 microglobulin in cerebrospinal fluid specimen (procedure) | 442037003 | |
| Adverse reaction to danaparoid (disorder) | 1187103009 | |
| Malignant neoplasm of spinal dura mater (disorder) | 188317004 | |
| Stomach ulcer excision (procedure) | 287832000 | |
| 120 minute plasma prolactin measurement (procedure) | 313892009 | |
| Antimony-116m (substance) | 5656008 | |
| Hyperinsulinism due to hepatocyte nuclear factor 4-alpha deficiency (disorder) | 717048002 | [A form of diazoxide-sensitive diffuse hyperinsulinism characterised by macrosomia, transient or persistent hyperinsulinaemic hypoglycaemia, responsiveness to diazoxide and a propensity to develop maturity-onset diabetes of the young subtype 1. The disease frequently presents as neonatal hypoglycaemia. All patients are responsive to medical management with diazoxide. Family history of diabetes is usually, but not always present. Caused by mutations in HNF4A gene (20q13.12). The transmission is autosomal dominant with variable penetrance., A form of diazoxide-sensitive diffuse hyperinsulinism characterized by macrosomia, transient or persistent hyperinsulinemic hypoglycemia, responsiveness to diazoxide and a propensity to develop maturity-onset diabetes of the young subtype 1. The disease frequently presents as neonatal hypoglycemia. All patients are responsive to medical management with diazoxide. Family history of diabetes is usually, but not always present. Caused by mutations in HNF4A gene (20q13.12). The transmission is autosomal dominant with variable penetrance.] |
| Total replacement of left knee joint (procedure) | 443681002 | |
| Lymphocyte positive for CD107A antigen (cell) | 117433008 | |
| Euroglyphus maynei protein (substance) | 711095008 | |
| Whole body bone imaging (procedure) | 228084000 | |
| Streptococcus pyogenes type emm57 (organism) | 442904003 |